StockData
EyePoint, Inc. logo

EyePoint, Inc. (EYPT) stock

EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.30−0.01 (-3.80%)

Close on Nov 17, 2026Market cap $25.51MP/E –Yield –

EyePoint total assets

Total assets on the balance sheet at the end of each period.

EyePoint's total assets was $228.19M at Jun 30, 2026. For fiscal 2025 it was $364.00M, down 13.0% from the year before. Over ten years it grew 32.0% a year on average. The highest annual figure on record is $418.47M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$364.00M-13.0%
FY2024Dec 31, 2024$418.47M+17.8%
FY2023Dec 31, 2023$355.18M+96.9%
FY2022Dec 31, 2022$180.36M-31.5%
FY2021Dec 31, 2021$263.37M+187.2%
FY2020Dec 31, 2020$91.72M+28.0%
FY2018Jun 30, 2018$71.67M+283.7%
FY2017Jun 30, 2017$18.68M-40.9%
FY2016Jun 30, 2016$31.62M-2.3%
FY2015Jun 30, 2015$32.37M+42.8%
FY2014Jun 30, 2014$22.67M+39.5%
FY2013Jun 30, 2013$16.25M-21.1%
FY2012Jun 30, 2012$20.60M-56.3%
FY2011Jun 30, 2011$47.11M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$228.19M-24.2%
Q1 FY2026CQ1 2026Mar 31, 2026$288.22M-20.5%
Q4 FY2025CQ4 2025Dec 31, 2025$364.00M-13.0%
Q3 FY2025CQ3 2025Sep 30, 2025$251.70M-16.4%
Q2 FY2025CQ2 2025Jun 30, 2025$301.15M-7.1%
Q1 FY2025CQ1 2025Mar 31, 2025$362.56M+10.1%
Q4 FY2024CQ4 2024Dec 31, 2024$418.47M+17.8%
Q3 FY2024CQ3 2024Sep 30, 2024$300.92M+88.0%
Q2 FY2024CQ2 2024Jun 30, 2024$324.25M+84.6%
Q1 FY2024CQ1 2024Mar 31, 2024$329.25M+113.0%
Q4 FY2023CQ4 2023Dec 31, 2023$355.18M+96.9%
Q3 FY2023CQ3 2023Sep 30, 2023$160.04M-27.4%
Q2 FY2023CQ2 2023Jun 30, 2023$175.66M-24.8%
Q1 FY2023CQ1 2023Mar 31, 2023$154.59M-36.8%
Q4 FY2022CQ4 2022Dec 31, 2022$180.36M-31.5%
Q3 FY2022CQ3 2022Sep 30, 2022$220.49M+31.0%
Q2 FY2022CQ2 2022Jun 30, 2022$233.43M+30.5%
Q1 FY2022CQ1 2022Mar 31, 2022$244.56M+30.7%
Q4 FY2021CQ4 2021Dec 31, 2021$263.37M+187.2%
Q3 FY2021CQ3 2021Sep 30, 2021$168.25M+119.1%
Q2 FY2021CQ2 2021Jun 30, 2021$178.82M+156.6%
Q1 FY2021CQ1 2021Mar 31, 2021$187.14M+133.1%
Q4 FY2020CQ4 2020Dec 31, 2020$91.72M+28.0%
Q3 FY2020CQ3 2020Sep 30, 2020$76.79M+53.1%
Q2 FY2020CQ2 2020Jun 30, 2020$69.69M+390.8%
Q1 FY2020CQ1 2020Mar 31, 2020$80.29M+502.5%
Q4 FY2018CQ2 2018Jun 30, 2018$71.67M+283.7%
Q3 FY2018CQ1 2018Mar 31, 2018$50.16M+186.5%
Q2 FY2018CQ4 2017Dec 31, 2017$14.20M-28.1%
Q1 FY2018CQ3 2017Sep 30, 2017$13.33M-46.5%
Q4 FY2017CQ2 2017Jun 30, 2017$18.68M-40.9%
Q3 FY2017CQ1 2017Mar 31, 2017$17.51M-51.6%
Q2 FY2017CQ4 2016Dec 31, 2016$19.75M-17.6%
Q1 FY2017CQ3 2016Sep 30, 2016$24.93M-9.2%
Q4 FY2016CQ2 2016Jun 30, 2016$31.62M-2.3%
Q3 FY2016CQ1 2016Mar 31, 2016$36.17M+1.3%
Q2 FY2016CQ4 2015Dec 31, 2015$23.95M–
Q1 FY2016CQ3 2015Sep 30, 2015$27.46M–
Q4 FY2015CQ2 2015Jun 30, 2015$32.37M–
Q3 FY2015CQ1 2015Mar 31, 2015$35.70M–

More EyePoint figures

See a number that looks wrong?